DK1222921T3 - Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid - Google Patents

Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid

Info

Publication number
DK1222921T3
DK1222921T3 DK02002887T DK02002887T DK1222921T3 DK 1222921 T3 DK1222921 T3 DK 1222921T3 DK 02002887 T DK02002887 T DK 02002887T DK 02002887 T DK02002887 T DK 02002887T DK 1222921 T3 DK1222921 T3 DK 1222921T3
Authority
DK
Denmark
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
DK02002887T
Other languages
Danish (da)
English (en)
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1222921(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Application granted granted Critical
Publication of DK1222921T3 publication Critical patent/DK1222921T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK02002887T 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid DK1222921T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
DK1222921T3 true DK1222921T3 (da) 2005-03-07

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02002887T DK1222921T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
DK98920285T DK1005342T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98920285T DK1005342T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid

Country Status (35)

Country Link
EP (2) EP1005342B1 (sk)
JP (1) JP3739802B2 (sk)
KR (2) KR100576646B1 (sk)
CN (2) CN1158074C (sk)
AP (1) AP1103A (sk)
AR (1) AR057242A2 (sk)
AT (2) ATE228839T1 (sk)
AU (1) AU740022B2 (sk)
BG (2) BG109365A (sk)
BR (1) BR9808722A (sk)
CA (2) CA2418634C (sk)
CZ (2) CZ298270B6 (sk)
DE (2) DE69827417T2 (sk)
DK (2) DK1222921T3 (sk)
EA (2) EA002920B1 (sk)
EE (1) EE04870B1 (sk)
ES (2) ES2232687T3 (sk)
GE (1) GEP20032970B (sk)
HK (1) HK1025907A1 (sk)
HU (1) HU229641B1 (sk)
IL (2) IL132516A (sk)
IS (1) IS2087B (sk)
LV (1) LV12492B (sk)
ME (1) ME00530B (sk)
NO (2) NO313983B1 (sk)
NZ (2) NZ513881A (sk)
OA (1) OA11169A (sk)
PL (1) PL193275B1 (sk)
PT (2) PT1005342E (sk)
RO (1) RO120605B1 (sk)
SI (1) SI20149B (sk)
SK (2) SK283946B6 (sk)
TR (1) TR199902733T2 (sk)
UA (2) UA57079C2 (sk)
WO (1) WO1998050035A1 (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
AU2007204963B2 (en) 2006-01-09 2012-09-27 Romark Laboratories, L.C. Viral hepatitis treatment
CA2752233C (en) * 2009-02-13 2017-01-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
CA2940954A1 (en) 2009-05-12 2010-11-18 Romark Laboratories L.C. Nitazoxanide and tizoxanide for the treatment of rhinovirus and rhabdovirus infections
ES2914949T3 (es) 2009-06-26 2022-06-17 Romark Laboratories Lc Compuestos y métodos para tratar la gripe
EP2808019B1 (en) 2012-01-27 2019-09-25 Siegfried Rhein S.A. De C.V. Improved nitazoxanide composition and preparation method thereof
TW201619142A (zh) * 2014-11-11 2016-06-01 羅馬克實驗室有限公司 利用替唑尼特（ｔｉｚｏｘａｎｉｄｅ）、其類似物或鹽類之前驅藥的組成物及治療方法
AU2019214347B2 (en) 2018-02-02 2023-09-28 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
RO120605B1 (ro) 2006-05-30
CA2288003C (en) 2003-10-21
WO1998050035A1 (en) 1998-11-12
JP2001503067A (ja) 2001-03-06
HUP0003330A2 (hu) 2001-05-28
DK1005342T3 (da) 2003-03-24
CN1552322A (zh) 2004-12-08
DE69827417T2 (de) 2005-10-27
EA199901012A1 (ru) 2000-08-28
CN1255060A (zh) 2000-05-31
TR199902733T2 (xx) 2000-03-21
CA2418634A1 (en) 1998-11-12
AU740022B2 (en) 2001-10-25
KR20010020322A (ko) 2001-03-15
EP1005342A4 (en) 2001-02-07
EA002908B1 (ru) 2002-10-31
CZ298269B6 (cs) 2007-08-08
SI20149A (sl) 2000-08-31
NO995406D0 (no) 1999-11-04
DE69809928T2 (de) 2003-04-24
IL132516A (en) 2003-12-10
IS2087B (is) 2006-03-15
SK283947B6 (sk) 2004-05-04
EP1222921A1 (en) 2002-07-17
CZ298270B6 (cs) 2007-08-08
IL132516A0 (en) 2001-03-19
EA200100956A1 (ru) 2002-02-28
KR100576646B1 (ko) 2006-05-08
EE9900578A (et) 2000-08-15
NZ500149A (en) 2001-11-30
AU7289598A (en) 1998-11-27
ME00530B (me) 2011-10-10
PT1222921E (pt) 2005-02-28
BG109365A (en) 2006-08-31
HK1025907A1 (en) 2000-12-01
EE04870B1 (et) 2007-08-15
PL336805A1 (en) 2000-07-17
SK283946B6 (sk) 2004-05-04
PT1005342E (pt) 2003-02-28
CN100515420C (zh) 2009-07-22
BG64973B1 (bg) 2006-11-30
NO335781B1 (no) 2015-02-16
DE69809928D1 (de) 2003-01-16
JP3739802B2 (ja) 2006-01-25
HUP0003330A3 (en) 2002-10-28
IS5223A (is) 1999-10-19
ES2232687T3 (es) 2005-06-01
KR20040004544A (ko) 2004-01-13
NO20021832D0 (no) 2002-04-18
ATE228839T1 (de) 2002-12-15
CA2288003A1 (en) 1998-11-12
LV12492B (en) 2001-01-20
SI20149B (en) 2001-08-31
AP1103A (en) 2002-09-04
HU229641B1 (en) 2014-03-28
EP1005342A1 (en) 2000-06-07
EP1005342B1 (en) 2002-12-04
OA11169A (en) 2003-04-25
AR057242A2 (es) 2007-11-21
BG103958A (en) 2000-07-31
ES2150404T3 (es) 2003-07-01
CZ391199A3 (cs) 2000-07-12
IL155799A (en) 2004-08-31
PL193275B1 (pl) 2007-01-31
UA57079C2 (uk) 2003-06-16
EA002920B1 (ru) 2002-10-31
DE69827417D1 (de) 2004-12-09
ATE281166T1 (de) 2004-11-15
NO313983B1 (no) 2003-01-13
CN1158074C (zh) 2004-07-21
GEP20032970B (en) 2003-05-27
IL155799A0 (en) 2003-12-23
KR100426657B1 (ko) 2004-04-13
NZ513881A (en) 2002-10-25
NO20021832L (no) 2000-01-04
LV12492A (en) 2000-06-20
ES2150404T1 (es) 2000-12-01
EP1222921B1 (en) 2004-11-03
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
BR9808722A (pt) 2000-07-11
SK151199A3 (en) 2000-07-11
UA74388C2 (uk) 2005-12-15
NO995406L (no) 2000-01-04

Similar Documents

Publication Publication Date Title
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
HUP0002686A3 (en) Guanidine mimics as factor xa inhibitors and pharmaceutical compositions containing the same
FI973475A (fi) Koostumus ja sitä sisältävä tuote
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
ZA983849B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
BR9509688A (pt) Composto e composição farmacêutica
DK1222921T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
IL136045A0 (en) Pyridylpyrrole derivatives and pharmaceutical compositions containing the same
NO20021241D0 (no) Farmasöytiske og/eller kosmetiske blandinger
BR9505130A (pt) Composto e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
BR1100838A (pt) Composto e composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
BR1100293A (pt) Composto e composição farmacêutica
BR1100809A (pt) Composto e composição farmacêutica
ZA989436B (en) Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
ITMI931417A1 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino
ITMI930118A1 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino